» Articles » PMID: 28529589

Tetrandrine Triggers an Alternative Autophagy in DU145 Cells

Overview
Journal Oncol Lett
Specialty Oncology
Date 2017 May 23
PMID 28529589
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Tetrandrine (Tet), a potent lysosomal inhibitor, blocks autophagic flux and induces cancer cell death. Previously, the present authors identified the prostate cancer cell line DU145 to exhibit high sensitivity towards Tet in 11 cancer cell lines. In the present study, autophagy in Tet-treated DU145 cells was investigated. Similar to other cell lines, such as PC-3 and 786-O cells, Tet neutralized the acidity of lysosome and blocked autophagy in DU145 cells. However, Tet failed to induce microtubule-associated protein 1 light chain 3 (LC3) conversion in DU145 cells. By contrast, it was observed by transmission electron microscopy that Tet induced an accumulation of autophagosomes in the cytoplasm. These contrasting results indicated that Tet triggered an LC3-independent autophagy in DU145 cells. Alkalizing lysosome with chloroquine enhanced Tet-induced cell death. The results of the present study indicated that detection of autophagy in tumor cells may assist in selecting lysosome inhibitors for chemotherapy treatment in prostate cancer.

Citing Articles

Tetrandrine targeting SIRT5 exerts anti-melanoma properties via inducing ROS, ER stress, and blocked autophagy.

Ji Y, Li C, Wan S, Dong Z, Liu C, Guo L J Pharm Anal. 2025; 14(10):101036.

PMID: 39850232 PMC: 11755340. DOI: 10.1016/j.jpha.2024.101036.


The Secrets of Alternative Autophagy.

Urbanska K, Orzechowski A Cells. 2021; 10(11).

PMID: 34831462 PMC: 8623506. DOI: 10.3390/cells10113241.


Potent antitumor activity of cepharanthine against triple-negative breast cancer spheroids compared with tetrandrine.

Kiyomi A, Miyakawa R, Matsumoto J, Yamazaki K, Imai S, Yuan B Oncol Lett. 2020; 20(6):331.

PMID: 33101499 PMC: 7577078. DOI: 10.3892/ol.2020.12191.


Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression.

Liao D, Zhang W, Gupta P, Lei Z, Wang J, Cai C Molecules. 2019; 24(23).

PMID: 31801248 PMC: 6930469. DOI: 10.3390/molecules24234383.


Self-Nanoemulsifying Drug Delivery System of Tetrandrine for Improved Bioavailability: Physicochemical Characterization and Pharmacokinetic Study.

Liu C, Lv L, Guo W, Mo L, Huang Y, Li G Biomed Res Int. 2018; 2018:6763057.

PMID: 30363745 PMC: 6180989. DOI: 10.1155/2018/6763057.

References
1.
Klionsky D, Abeliovich H, Agostinis P, Agrawal D, Aliev G, Askew D . Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy. 2008; 4(2):151-75. PMC: 2654259. DOI: 10.4161/auto.5338. View

2.
Wu S, Ng L . Tetrandrine inhibits proinflammatory cytokines, iNOS and COX-2 expression in human monocytic cells. Biol Pharm Bull. 2007; 30(1):59-62. DOI: 10.1248/bpb.30.59. View

3.
Gong K, Chen C, Zhan Y, Chen Y, Huang Z, Li W . Autophagy-related gene 7 (ATG7) and reactive oxygen species/extracellular signal-regulated kinase regulate tetrandrine-induced autophagy in human hepatocellular carcinoma. J Biol Chem. 2012; 287(42):35576-35588. PMC: 3471698. DOI: 10.1074/jbc.M112.370585. View

4.
Huang A, Lien J, Lin M, Yang J, Wu P, Chang S . Tetrandrine induces cell death in SAS human oral cancer cells through caspase activation-dependent apoptosis and LC3-I and LC3-II activation-dependent autophagy. Int J Oncol. 2013; 43(2):485-94. DOI: 10.3892/ijo.2013.1952. View

5.
Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T . Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature. 2009; 461(7264):654-8. DOI: 10.1038/nature08455. View